Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here

The CHIME radio telescope at the Dominion Radio Astrophysical Observatory in Kaleden, British Columbia, Canada

The CHIME radio telescope has detected 535 fast radio bursts in its first year of operation.Credit: Andre Renard/CHIME Collaboration

Fast radio bursts have two types

A bumper crop of fast radio bursts (FRBs) shows that the mysterious signals come in two distinct types. The Canadian Hydrogen Intensity Mapping Experiment (CHIME) radio telescope has detected 535 FRBs — quadrupling the known tally of these powerful cosmic flashes, which flare for just milliseconds. Most of them are one-offs, but a minority repeat periodically and last at least ten times longer than average. The findings suggest that FRBs might originate from at least two astrophysical phenomena — bringing us a step closer to solving one of astronomy’s biggest puzzles.

Nature | 5 min read

Anti-dengue mosquito trial success

Cases of dengue fever plummeted by a “staggering” 77% after researchers released modified mosquitoes that are resistant to the virus. These mosquitoes carry dengue-blocking Wolbachia bacteria, which they spread through local mosquito populations. Wolbachia-carrying mosquitoes were released over a six-month period in randomly designated parts of Yogyakarta in Indonesia, starting in 2017. Early results last August were so encouraging that researchers have since released Wolbachia-carrying mosquitoes over all of central Yogyakarta and plan to expand the project.

The Atlantic | 6 min read

Read more: Meet public-health researcher Adi Utarini, who is leading this completely new approach to controlling dengue (Nature’s 10 | 4 min read, from December)

Reference: New England Journal of Medicine paper

COVID-19 coronavirus update


Four urgent questions about long COVID

The number of confirmed COVID-19 cases has topped 170 million across the globe, and upwards of 10% of those people might be experiencing persistent symptoms. Among the questions that scientists are investigating: who is most at risk, what are the underlying mechanisms and how might long COVID offer insight into other post-viral problems? And, of course, how can it be treated? “How can we get better?” asks Claire Hastie, who has the condition. “That’s what we want to know.”

Nature | 13 min read


How Alpha blunts our immune defences

Since it was first detected in the United Kingdom late last year, the coronavirus variant B.1.1.7 — also called Alpha — has surged around the world and become the dominant form of SARS-CoV-2. Some studies show that Alpha’s ability to outstrip previously circulating variants could stem from mutations in its spike protein, which help it to enter cells more efficiently. A new study suggests that Alpha also has tricks linked to mutations outside the spike protein that allow it suppress the rapid-response defence that the body mounts against all invaders. By blocking this ‘innate immune response’, the virus might buy itself more opportunities to infect other people.

Nature | 4 min read

Reference: bioRxiv preprint


Scientists warn of risk at Tokyo Olympics

More than a dozen scientists in Japan, including senior advisers on the government’s pandemic response, recommend barring or limiting spectators from attending the Tokyo Olympics and Paralympics. Most of the scientists would have prefered to cancel the games altogether. They warn that the event, which is set to begin on 23 July, could spur the spread of SARS-CoV-2 domestically and internationally, including more transmissible variants. Japan and the International Olympic Committee have already barred tourists from entering Japan to watch the games, but millions of Japanese residents can attend.

Science | 6 min read

Notable quotable

“[The] present solution, although not perfect, is a simple, straightforward alternative for variants that are otherwise being named after places.”

Even though it’s fast running out of letters, the World Health Organization’s new greek-letter names for coronavirus variants beat geographical nicknames that can cause stigma, argues a Nature editorial.

Features & opinion

Setbacks that can help your start-up succeed

Cash-flow challenges and team tensions are just two of the issues a fledgling business can face. Learn from them and move on, seasoned entrepreneurs tell Nature’s Working Scientist podcast. “Things never go exactly as you expect, even when things are going well,” says Barbara Domayne-Hayman, entrepreneur in residence at the Francis Crick Institute in London. “Resilience is the single most important thing that you need to have.”

Nature Careers Podcast | 19 min listen

Is Mars ours?

With landers from NASA and China recently dropping onto the surface of Mars, scientists are pondering whether we should treat the planet like a resource to exploit or a place to protect. Critics of unfettered human activity point to the lessons from the history of exploration and colonization on Earth. And they note that space exploration already presents ethical quandaries, such as the proliferation of space junk and placing telescopes on sacred land. “There’s a whole system built around this idea of space exploration being ethical and pro-human, but it’s also one that doesn’t necessarily hear voices from non-Western perspectives,” says Mi’kmaq astronomer Hilding Neilson. “It has to be about being part of Mars, as opposed to making Mars part of us.”

The New Yorker | 14 min read

Image of the week

A herd of wild elephants cuddles as they rest near a village in Xiyang township, China. For reasons unknown, the 15 animals have spent months travelling hundreds of kilometres across the country from their home on a nature reserve. The elephants are beloved social-media stars that authorities are carefully protecting, despite their eating millions of dollars worth of crops, damaging buildings and startling people in their homes. (BBC | 3 min read) (Xinhua/Shutterstock)

Quote of the day

“The teams carrying out data analysis and field investigations and launching communication drives or laboratory studies have experienced the joy of knowing their collective efforts can achieve something none of them could do on their own.”

On her retirement as the principal deputy director of the US Centers for Disease Control and Prevention, Anne Schuchat makes an impassioned call for the value of public service. (The New York Times | 6 min read)